In vitro efficacy of acetohydroxyacid synthase inhibitors against clinical strains of mycobacterium tuberculosis isolated from a hospital in Beijing, China

Saudi Medical Journal

Volumn 32, Issue 11, 2011, Pages 1122-1126

  Dong, Mei ^a   Wang, Di ^a   Jiang, Ying ^a   Zhao, Li ^a   Yang, Caie ^a   Wu, Chun ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOLACTATE SYNTHASE INHIBITOR; MONOSULFURON; MONOSULFURON ESTER; SULFOMETURON METHYL; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

AGAR MEDIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CHINA; CYTOTOXICITY; DRUG EFFICACY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ACETOLACTATE SYNTHASE; ANTITUBERCULAR AGENTS; CHINA; MICROBIAL SENSITIVITY TESTS;

EID: 81755181863     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. World Health Organization. Multidrug and extensively drugresistant tuberculosis: 2010 Global report on surveillance and response. Geneva: World Health Organization; 2010.
2. World Health Organization. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81: 430-432.
3. McCourt JA, Pang SS, King-Scott J, Guddat LW, Duggleby RG. Herbicide-binding sites revealed in the structure of plant acetohydroxyacid synthase. Proc Natl Acad Sci U S A 2006; 103: 569-573.
4. Singh V, Chandra D, Srivastava B S, Srivastava R. Biochemical and transcription analysis of acetohydroxyacid synthase isoforms in Mycobacterium tuberculosis identifies these enzymes as potential targets for drug development. Microbiology 2011; 157: 29-37.
5. Wang JG., Li ZM, Ma N, Wang BL, Jiang L, Pang SS, et al. Structure-activity relationships for a new family of sulfonylurea herbicides. J Comput Aided Mol Des 2005; 19: 801-820.
6. Choi KJ, Yu YG, Hahn HG, Choi JD, Yoon MY. Characterization of acetohydroxyacid synthase from Mycobacterium tuberculosis and the identification of its new inhibitor from the screening of a chemical library. FEBS Lett 2005; 579: 4903-4910.
7. Sohn H, Lee KS, Ko YK, Ryu JW, Woo JC, Koo DW, et al. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and nontuberculous mycobacteria. Int J Antimicrob Agents 2008; 31: 567-571.
8. Wang D, Yang C, Kuang T, Lei H, Meng X, Tong A, et al. Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study. Jpn J Infect Dis 2010; 63: 368-371.
9. Ingham CJ, Ayad AB, Nolsen K, Mulder B. Rapid drug susceptibility testing of mycobacteria by culture on a highly porous ceramic support. Int J Tuberc Lung Dis 2008; 12: 645-650.
10. Zhong Y, Zhang XH, Chen J, Chi Z, Sun B, Li Y, et al. Overexpression, purification, characterization, and pathogenicity of Vibrio harveyi hemolysin VHH. Infect Immun 2006; 74: 6001-6005.
11. Li QT, Zhu YZ, Chu JY, Dong K, He P, Feng CY, et al. Granulocyte-macrophage colony-stimulating factor DNA prime-protein boost strategy to enhance efficacy of a recombinant pertussis DNA vaccine. Acta Pharmacol Sin 2006; 27: 1487-1494.
12. He GX, Xie YG, Wang LX, Borgdorff MW, Werf MJ, Fan JHB. Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment. PLoS One 2010; 5: e10799.
13. Wang JG, Lee PK, Dong YH, Pang SS, Duggleby RG, Li ZM, et al. Crystal structures of two novel sulfonylurea herbicides in complex with Arabidopsis thaliana acetohydroxyacid synthase. FEBS J 2009; 276: 1282-1290.